Retransplantation After Acquired Transthyretin Amyloidosis Following Domino Liver Transplantation: Outcomes and Challenges

Liver retransplantation appears to offer limited benefit in halting disease progression in acquired ATTR amyloidosis, particularly when performed at advanced stages. Earlier intervention, before the establishment of significant systemic involvement, may improve outcomes. These findings highlight the need for timely diagnosis and individualized management in this underrecognized condition.